Pediatric vaccine market to reach $107.8 billion by 2030 at 13.5% cagr, driven by rising prevalence of pediatric diseases.
Read MorePediatric supplements market to reach $5.76 billion by 2030 at 6.5% cagr, driven by growing prevalence of nutritional deficiencies.
Read MoreThe global pediatric drugs market to reach $352.69 billion by 2030 at 14.4% cagr, driven by growing number of preterm births.
Read MorePediatric asthma treatment market to reach $15.14 billion by 2030 at 5.3% cagr, driven by increasing prevalence of respiratory infections.
Read MorePeanut allergy treatment market to reach $0.8 billion by 2030 at 9.7% cagr, driven by investment in research and development of allergy treatments.
Read MorePeanut allergy treatment market to reach $0.8 billion by 2030 at 9.7% cagr, driven by investment in research and development of allergy treatments.
Read MorePd-1 and pdl1 inhibitors immune checkpoint inhibitors market to reach $103.27 billion by 2030 at 14.6% cagr, driven by rising prevalence of cancer cases.
Read MorePcsk9 inhibitor market to reach $8.28 billion by 2030 at 20.6% cagr, driven by increasing hyperlipidemia prevalence.
Read MoreThe global parenteral nutrition market to reach $9.49 billion by 2030 at 6.0% cagr, driven by increasing birth rate.
Read MoreThe global parathyroid hormone market to reach $4.4 billion by 2030 at 11.9% cagr, driven by increasing geriatric population.
Read More